Advertisement
UK markets close in 7 hours 50 minutes
  • FTSE 100

    8,079.07
    +38.69 (+0.48%)
     
  • FTSE 250

    19,608.50
    -110.87 (-0.56%)
     
  • AIM

    753.87
    -0.82 (-0.11%)
     
  • GBP/EUR

    1.1660
    +0.0015 (+0.13%)
     
  • GBP/USD

    1.2498
    +0.0035 (+0.28%)
     
  • Bitcoin GBP

    51,308.16
    -2,139.87 (-4.00%)
     
  • CMC Crypto 200

    1,390.10
    +7.53 (+0.54%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.95
    +0.14 (+0.17%)
     
  • GOLD FUTURES

    2,333.90
    -4.50 (-0.19%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,278.56
    +77.29 (+0.45%)
     
  • DAX

    17,987.69
    -101.01 (-0.56%)
     
  • CAC 40

    8,064.19
    -27.67 (-0.34%)
     

Roche Proves Again Why It Will Likely Rout Shire's Hemophilia Business

Roche Proves Again Why It Will Likely Rout Shire's Hemophilia Business

Roche jumped early Monday on unsurprisingly strong data for its hemophilia treatment, Hemlibra — prodding shares of Shire to slip.